Glutaminase (GLS1) gene expression in primary breast cancer
CONCLUSION: GLS1 expression is highest in TNBC and basal breast cancer, supporting ongoing clinical investigation of GLS1 inhibition in TNBC. GLS1 may have prognostic implications but further research is needed to validate this finding. GLS1 had significant positive gene correlations with immune genes, which may have implications for potential combinations of glutaminase inhibition and immunotherapy.PMID:37679553 | DOI:10.1007/s12282-023-01502-0
Source: Breast Cancer - Category: Cancer & Oncology Authors: Neelima Vidula Christina Yau Hope S Rugo Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | HER2 | Hormones | Immunotherapy | Statistics